Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Nov. 30, 2025	Nov. 30, 2024
Operating activities:
Net income	$ 9,320	$ 6,888
Adjustments to reconcile net income to net cash (used in) provided by operating activities:
Depreciation and amortization	428	433
Increase in allowance for credit losses	29	66
Deferred tax provision	(5)	(48)
Unrealized (gain) loss on trading securities	241	(213)
Increase (decrease) in cash flow from change in:
Trade accounts receivable	8,323	1,470
Inventory	(4,625)	(6,081)
Prepaid expenses and other assets	(1,116)	(995)
Operating lease right-of-use assets	(2,129)	583
Trade accounts payable	(914)	3,328
Accrued expenses and other current liabilities	(12,368)	(2,840)
Operating lease liabilities	2,233	(578)
Net cash provided by operating activities	(584)	2,013
Investing activities:
Additions to property, equipment, and leasehold improvements	(1,177)	(131)
(Purchase) sale of marketable securities, trading	415	(5,560)
Net cash (used in) investing activities	(762)	(5,691)
Financing activities:
Borrowing on revolving credit facility	3
Preferred stock dividend	(19)	(19)
Repayments on long-term debt	(35)	(31)
Bank overdraft	1,213	3,511
Net cash (used in) financing activities	1,162	3,461
Effect of foreign currency exchange rate changes on cash and cash equivalents	(8)	(35)
Net (decrease) in cash, cash equivalents, and restricted cash	(191)	(252)
Cash, cash equivalents, and restricted cash - beginning of period	738	853
Cash, cash equivalents, and restricted cash - end of period	547	601
Supplemental disclosures of cash flow information:
Cash paid for interest	37	48
Cash paid for income taxes	$ 6,982	$ 9,211